TY  - JOUR

T1  - Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.

JO  - Int J Cancer

PY  - 2010/01/01

AU  - Ottewell PD

AU  - Lefley DV

AU  - Cross SS

AU  - Evans CA

AU  - Coleman RE

AU  - Holen I

ED  - 

DO  - DOI: 10.1002/ijc.24756

VL  - 126

IS  - 2

SP  - 522

EP  - 532

Y2  - 2024/12/21

ER  -